Chancery’s Reversal on Damages Opinion Bodes Well for Plaintiff

Business Valuation UpdateVol. 20 No. 11
Legal and Court Case Update
November 2014

Access the Full Article

This article is available with a subscription to any of these products:
It is also available in this product:
Already a subscriber or product owner?  Login
This article is also available for purchase. (2,165 words)   Add to Cart >>
Need help? Contact us:
1-503-479-8200 ext 2 or sales@bvresources.com
2834 Pharmaceutical Preparations
325412 Pharmaceutical Preparation Manufacturing
economic damages & lost profits
lost profits, expert testimony, pharmaceutical, contract, contractual remedy, expectation damages, license agreement
PharmAthene, Inc. v. SIGA Technologies, Inc.
2014 Del. Ch. LEXIS 142
August 8, 2014
US
State Court
Delaware
Court of Chancery
Jeffrey L. Baliban (plaintiff); Dr. Keith Ugone (defendant)
Parsons

Summary

In a major pharmaceutical case, on remand Delaware Chancery finds plaintiff proved it had a reasonable expectation of profits at the time of breach; court accepts plaintiff expert’s damages model, but orders adjustments, particularly to sales quantity.

See Also

PharmAthene, Inc. v. SIGA Technologies, Inc.

Full Text of Court Cases
August 8, 2014

In a major pharmaceutical case, on remand Delaware Chancery finds plaintiff proved it had a reasonable expectation of profits at the time of breach; court accepts plaintiff expert’s damages model, but orders adjustments, particularly to sales quantity.

This article also appears in:
Business Valuation UpdateVol. 20 No. 11
The Comprehensive Guide to Economic Damages, Seventh Edition